Parkinsonism Relat Disord
Drug DiscoveryNational Institute of Neurological Disorders and Stroke (U.S.)Parkinson Disease
Dr. Andrew M. Goldfine, MD
NPI1104013325
- Medicare services, 2017
- 16,024
- Part D claims, 2018
- 92
- Publications
- 23
- Clinical trials
- 3
- Industry payments
- $2,786
- Practice address
- Neurology Associates Of Stony Brook Ufpc, Stony Brook, NY 11794-8121
- Practice phone
- Call (631) 444-2599
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Goldfine's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Andrew M. Goldfine is a neurologist in Stony Brook, New York
Dr. Goldfine practices in Stony Brook, New York.
Dr. Goldfine's NPI, 1104013325, was assigned on October 2, 2007. Dr. Goldfine graduated from Rutgers Robert Wood Johnson Medical School in 2003. Dr. Goldfine's New York license number on file is 235887.
NPI and contact details
- NPI
- 1104013325NPI Registry (opens in a new tab)
- NPI enumeration date
- October 2, 2007
- NPI status
- Active
- Practice phone
- (631) 444-2599
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Andrew M. Goldfine's practice address is in Stony Brook, New York
Dr. Goldfine's practice address in the NPI Registry is Neurology Associates Of Stony Brook Ufpc, Stony Brook, NY 11794-8121. The practice phone is (631) 444-2599.
- NPI Registry addressNeurology Associates Of Stony Brook Ufpc, Stony Brook, NY 11794-8121Phone(631) 444-2599
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Andrew M. Goldfine's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldfine practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Goldfine's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Goldfine practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Andrew M. Goldfine is one of 1,489 neurologists in New York
Neurology is Dr. Goldfine's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Goldfine is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Goldfine's licenses on file in 4 states: New York, California, Pennsylvania and New Jersey.
Specialties and state licenses
- Neurology, New YorkPrimary
- California license
- Pennsylvania license
- New Jersey license
Neurologists near Dr. Goldfine
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
1,489neurologists in New York
8neurologists in Stony Brook
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Andrew M. Goldfine billed Medicare for 16,024 services in 2017
CMS data shows 16,024 Medicare services from Dr. Goldfine across 13 procedure codes in 2017. Medicare paid $96,170 for them.
Medicare services, 201716,024
Paid by Medicare$96,170
Procedure codes13
Dr. Goldfine's Medicare services by type, 2016 to 2017
- 2016
- 2017
- Drugs given in the office
- 2016: 5,8002017: 15,700171%
- Office and hospital visits
- 2016: 2002017: 1905%
- Surgery
- 2016: 02017: 90
- Imaging
- 2016: 02017: 44
Where Dr. Goldfine's Medicare services took place, 2017
- In an office15,979100%
- In a facility450%
Dr. Goldfine compared with the New York median for neurologists, 2017
- Dr. Goldfine
- New York median
- Medicare services
- 16,024vs 37642.6 times
- Part D claims
- 92vs 37575% below
Medians across 1,462 neurologists in New York with Dmand AI profiles that report each measure.
Dr. Goldfine's most billed Medicare procedure codes, 2017
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Goldfine?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Goldfine and other neurologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Andrew M. Goldfine's patients have a median age of 47
Across all payers, Dmand AI patient panel data puts Dr. Goldfine's median patient age at 47, with 88% women.
Dr. Goldfine's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 47
Patient panel by sex, all payers
- Women88%
- Men13%
Source: Dmand AI Patient Panel Data
Dr. Andrew M. Goldfine wrote 92 Medicare Part D claims in 2018
In 2018, Dr. Goldfine wrote 92 Medicare Part D claims. They cover 6 drugs, with $2,673 in total drug cost. In 2017, CMS named 615 claims across 24 drugs.
Part D claims, 201892
Drugs named by CMS6
Total drug cost$2,673
Dr. Goldfine's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 6152018: 9285%
Drugs named by CMS: 6 in 2018, 24 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find neurologists like Dr. Goldfine by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Andrew M. Goldfine has 23 publications on record
Dmand AI links 23 papers to Dr. Goldfine, published from 2006 to 2021. 2011 was the busiest year, with 5. The most frequent topics are Brain, Electroencephalography and Brain Injuries. Dr. Goldfine has published most often in Curr Opin Neurol. Dr. Goldfine's most frequent co-authors are Nicholas D. Schiff, MD, Ari L. Harris, MD and Ted Murray Dawson, MD.
Papers23
Years published2006 to 2021
Dr. Goldfine's papers by year, 2006 to 2021
Topics Dr. Goldfine writes about most
- Brain
- Electroencephalography
- Brain Injuries
- Apathy
- Awareness
- Brain Mapping
- Magnetic Resonance Imaging
- Motor Activity
Dr. Goldfine's most frequent co-authors
- Nicholas D. Schiff, MD9 shared papers
- Ari L. Harris, MD2 shared papers
- Ted Murray Dawson, MD1 shared paper
Recent publications by Dr. Goldfine
Basal GangliaBrain MappingCerebral Cortex
Neuroimage Clin
AttentionBrain Injuries, TraumaticCognition Disorders
J Neuropsychiatry Clin Neurosci
ActigraphyApathyBehavioral Symptoms
See who Dr. Goldfine researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Goldfine works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Andrew M. Goldfine has worked on 3 clinical trials
Dmand AI links Dr. Goldfine to 3 clinical trials. Conditions studied include Anhedonia, Cognitive Dysfunction and Parkinson Disease. Stony Brook University sponsors the most, 2.
Conditions in Dr. Goldfine's trials
- Anhedonia
- Cognitive Dysfunction
- Parkinson Disease
- Cognition Disorders
- Lethargy
Recent clinical trials with Dr. Goldfine
Parkinson DiseaseParkinsonian DisordersK0706
Cognitive DysfunctionCognition DisordersTranscranial Direct Current Stimulation
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy (opens in a new tab)
Terminated
AnhedoniaLethargyTranscranial Direct Current Stimulation
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Andrew M. Goldfine received $2,786 in industry payments from 2016 to 2019
CMS Open Payments shows 37 general payments to Dr. Goldfine from 7 drug and device companies from 2016 to 2019. Travel and lodging make up the largest share, 59% of the total. Medtronic USA, Inc. paid the most, $1,192.
General payments to Dr. Goldfine by program year, 2016 to 2019
General payments to Dr. Goldfine by kind, 2016 to 2019
$2.8Kin total
- Travel and lodging$1,65159%
- Food and beverage$1,11840%
- Education$171%
Companies that paid Dr. Goldfine the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Andrew M. Goldfine graduated from Rutgers Robert Wood Johnson Medical School
Dr. Goldfine graduated from Rutgers Robert Wood Johnson Medical School in 2003.
- Medical school
- Board certified in neurology
- Board certified in neurorehabilitation and neural repair
Source: Dmand AI Professional Profile Data
Sources for Dr. Andrew M. Goldfine's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Andrew M. Goldfine
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Andrew M. Goldfine's NPI number?
Dr. Andrew M. Goldfine's NPI number is 1104013325. It was assigned on October 2, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Andrew M. Goldfine?
Dr. Andrew M. Goldfine is a neurologist in Stony Brook, New York. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Andrew M. Goldfine practice?
Dr. Goldfine practices at Neurology Associates Of Stony Brook Ufpc, Stony Brook, NY 11794-8121.
What is Dr. Andrew M. Goldfine's office phone number?
The practice phone on file for Dr. Goldfine is (631) 444-2599.
What is Dr. Andrew M. Goldfine's medical license number?
Dr. Goldfine's New York license number on file is 235887, one of the licenses on file in 4 states.
Which states has Dr. Andrew M. Goldfine been licensed in?
Dmand AI has state licenses on file for Dr. Goldfine in New York (2005 to 2018), California (since 2007), Pennsylvania (2021 to 2026) and New Jersey (2018 to 2023).
Does Dr. Andrew M. Goldfine accept Medicare?
Yes. CMS data shows Dr. Goldfine billed Medicare for 16,024 services in 2017.
Is Dr. Andrew M. Goldfine board certified?
Yes. Dr. Goldfine is board certified in neurology by the American Board of Psychiatry and Neurology.
What services does Dr. Andrew M. Goldfine bill to Medicare?
In 2017, Dr. Goldfine's most billed Medicare services were injected or infused drug (J0588), injected or infused drug (J0585) and office visit, established patient (99214).
Where did Dr. Andrew M. Goldfine go to medical school?
Dr. Goldfine graduated from Rutgers Robert Wood Johnson Medical School in 2003.
Show 5 more questionsShow fewer questions
What drugs does Dr. Andrew M. Goldfine prescribe most?
In 2018 Medicare Part D data, Dr. Goldfine's most prescribed drugs by claims were Lamotrigine, Donepezil HCl and Levetiracetam.
Has Dr. Andrew M. Goldfine received payments from drug or device companies?
CMS Open Payments shows $2,786 in general payments to Dr. Goldfine from 7 companies from 2016 to 2019. The largest total came from Medtronic USA, Inc.
How long has Dr. Andrew M. Goldfine been practicing?
Dr. Goldfine graduated from medical school in 2003, 23 years ago.
Does Dr. Andrew M. Goldfine do research?
Dmand AI links 23 publications to Dr. Goldfine, published from 2006 to 2021. Dr. Goldfine has worked on 3 clinical trials.
Who does Dr. Andrew M. Goldfine publish with?
Dr. Goldfine's most frequent co-authors are Nicholas D. Schiff, MD (9 shared papers), Ari L. Harris, MD (2 shared papers) and Ted Murray Dawson, MD (1 shared paper).
Selling to neurology practices?
See neurologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card